InhaLac® 145
Premium milled DPI alpha-lactose monohydrate – Ph. Eur., USP-NF, JP, ChP
Milled DPI lactose, with its fine particle size and increased surface area, improves drug adhesion and detachment, optimizing the delivery of active ingredients to the lower respiratory tract.
InhaLac® 145 is a milled lactose monohydrate with a median particle size (x50) of ~125 µm, tailored for DPI formulations needing improved flow properties and consistent performance.
Benefits
- A broad spectrum of particle size distributions
- High storage stability
- Highly controlled and homogenous powder characteristics
- Highest microbial quality including low endotoxins
Areas of Application
- InhaLac® 145 is a milled lactose suitable for use in pulmonary and nasal drug delivery.
Order your free sample!
- Dry Powder Inhalation
- Milled Lactose DPI
- Inhalation Lactose
- Inhalation
- Dry Powder Inhaler (DPI)
- Capsule Device (DPI)
- Blister Device (DPI)
20kg – Carton box with aluminium laminated and PE-EVOH-PE inliner
24 months
Wasserburg am Inn, Germany
Downloads
Typical particle size distribution
Typical Product Data
- x10: 4.4 µm, x50: 34 µm, x90: 102 µm
- Span [(x90-x10)/x50]: 2.9
- % fines <5 µm: 11
- Density bulk: 0.54 g/ml
- Density tapped: 0.87 g/ml
- Hausner Ratio: 1.61
- Carr’s Index: 38 %
Specified Product Data
Particle size distribution
Sieve Method: Laser diffraction
- x10: 1-6
- x50: 20-50
- x90: 65-140
Do you have any questions or need a customised solution?